Cordyceps sinensis for hypertension in adults
References
Additional references
Buenz EJ, Bauer BA, Osmundson TW, Motley TJ. The traditional Chinese medicine Cordyceps sinensis and its effects on apoptotic homeostasis. Journal of Ethnopharmacology2005; Vol. 96, issue 1‐2:19‐29.
Carlene M M Lawes SVH, Anthony Rodgers, for the International Society of Hypertension. Global burden of blood‐pressure‐related disease, 2001. Lancet2008; Vol. 371, issue 9623:1513‐8. [1474‐547X: (Electronic)]
Carretero OA, Oparil S. Essential hypertension. Circulation 2000;101:329.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA2003; Vol. 289, issue 19:2560‐72.
Ezzati M LA, Rodgers A, Vander Hoorn S, Murray CJ, Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet2002; Vol. 360, issue 9343:1347‐60. [0140‐6736: (Print)]
Jan Brozek, Andrew Oxman, Holger Schunemann. GRADEpro. Version Version 3.2 for Windows. The GRADE Working Group, 2008.
Hackam DG, Khan NA, Hemmelgarn BR, Rabkin SW, Touyz RM, Campbell NR, et al. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 ‐ therapy. Canadian Journal of Cardiology2010; Vol. 26, issue 5:249‐58.
Higgins JPT, Altman DG. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated September 2008). The Cochrane Collaboration, 2008:Available from www.cochrane‐handbook.org.
Higgins JPT, Deeks JJ, Altman DG. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 (updated September 2009). The Cochrane Collaboration, 2009:Available from www.cochrane‐handbook.org.
Illana Esteban C. Cordyceps sinensis, a fungi used in the Chinese traditional medicine. Rev Iberoam Micol2007; Vol. 24, issue 4:259‐62. [1130‐1406: (Print)]
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet2005; Vol. 365, issue 9455:217‐23.
Koh JH, Kim KM, Kim JM, Song JC, Suh HJ. Antifatigue and antistress effect of the hot‐water fraction from mycelia of Cordyceps Sinensis. Biological and Pharmaceutical Bulletin2003; Vol. 26, issue 5:691‐4.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med2009; Vol. 6, issue 7:e1000100.
National Blood Pressure and Vascular Disease Advisory Committee. Guide to management of hypertension 2008: Assessing and managing raised blood pressure in adults. Web version 2009. Canberra: National Heart Foundation of Australia, August 2009:36.
Oparil S, Weber MA. Hypertension : a companion to Brenner and Rector's the kidney. 2nd Edition. Philadelphia: Saunders, 2005. [0721602584]
Paterson RR. Cordyceps: a traditional Chinese medicine and another fungal therapeutic biofactory?. Phytochemistry2008; Vol. 69, issue 7:1469‐95.
The Cochrane Collaboration. Review Manager (RevMan). Version 5. Copenhagen: The Nordic Cochrane Centre, 2008.
Schneider RH, Alexander CN, Staggers F, Rainforth M, Salerno JW, Hartz A, et al. Long‐term effects of stress reduction on mortality in persons > or = 55 years of age with systemic hypertension. American Journal of Cardiology2005; Vol. 95, issue 9:1060‐4.
SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA1991; Vol. 265, issue 24:3255‐64. [0098‐7484: (Print)]
Spence JD, Barnett PA, Linden W, Ramsden V, Taenzer P. Lifestyle modifications to prevent and control hypertension. 7. Recommendations on stress management. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. CMAJ1999; Vol. 160, issue 9 Suppl:S46‐50.
StataCorp LP. Stata Statistical Software. Version Release 10. TX: College Station, 2007.
Whitworth JA. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. Journal of Hypertension2003; Vol. 21, issue 11:1983‐92.
World Health Organization. Global health risks. Mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization Press, 2009.
Wright JM, Musini VM. First‐line drugs for hypertension. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD001841.pub2]
Figures and Tables -
Figure 1
Flow of information through the different phases of a systematic review (Liberati 2009)
